NetraMark Holdings Inc C.AIAI

Alternate Symbol(s): AINMF

Technology Software - Application

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.

CSE:AIAI - Post by User

NetraMark Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by yopmemama021on Feb 28, 2022 4:48pm

203 Views

Post# 34469145

MEND

wrapping up a solid month for $MEND.c $MNNDF

they partnered up with Cyclica to develop novel drugs for neurodegenerative diseases and had George Achilleos take over as CEO.

they launched their game changing AI technology, Netraplacebo, which will transform clinical trial success rates in the US$94B CNS therapeutics Market. $MEND ’s AI can create accurate hypotheses in less than an hour, about diseases that have taken years for pharmaceutical companies to discover

hoping soon with enough volume to see some price action start to reflect these major advancements

$MEND.c steady @$0.68 ,tight share structure with only 40 M OS

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks